Evidence map›Paper›PMID 40187728›Full record

ArticleJournal of advanced research2026

Screening, identification and detection of the regulated and emerging mycotoxins in edible and medicinal products by integrating diversiform liquid chromatography/mass spectrometry systems and high-throughput sequencing of contaminated fungi.

Xiao-Yan Xu, Yu Wang, Lian-Xing Wang, Xue Li, Meng-Yao Wang, Hong-da Wang, Fei-Yang Yu, Ya-Dan Zou, Miao-Miao Jiang, Yue-Fei Wang and 1 more

Abstract read
In one paragraph

Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiao-Yan XuState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Yu WangState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Lian-Xing WangState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Xue LiState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China. Electronic address: tjdxsyx@163.com.
Meng-Yao WangState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Hong-da WangState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Fei-Yang YuState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Ya-Dan ZouState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Miao-Miao JiangState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China.
Yue-Fei WangState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China. Electronic address: wangyf0622@tjutcm.edu.cn.
Wen-Zhi YangState Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, 10 Poyanghu Road, Tianjin 301617, China. Electronic address: wzyang0504@tjutcm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSafety issues pertaining to mycotoxin contamination of the edible and medicinal products (EMPs) have attracted significant attention. EMPs not only have high nutritional values, but also exert valuable medicinal properties. Innumerable EMPs have been found to be contaminated by the multi-class mycotoxins, comprising both the parent and modified mycotoxins. Regular analysis can frequently overlook the modified forms, causing the mycotoxin contamination to be underestimated. To guarantee the safety of EMPs, it is crucial to establish a systematic and efficient analysis strategy enabling the extensive detection of mycotoxins.

objectivesA strategy was designed for the screening, identification, and detection of mycotoxins in EMPs.

methodsBased on an in-house library containing 781 compounds, targeted/untargeted screening of the mycotoxins was achieved by multiple reaction monitoring (MRM) of tandem mass spectrometry and data-dependent acquisition with a preferred precursor ions list of the Orbitrap Exploris mass spectrometry, coupled with the liquid chromatography separation. A fully validated scheduled MRM approach could enable the accurate determination of 15 mycotoxins. The fungal community and potential toxigenic fungi were analyzed via high-throughput sequencing.

resultsCo-occurrence of mycotoxins was observed in 105 batches of EMPs samples. Aflatoxins B

conclusionsThese findings can provide an early warning for mycotoxins contamination of EMPs, and unveil that the edible and medicinal plant seeds and fruits are susceptible to fungi and mycotoxins contamination. The proposed strategy, with the merits of simple pretreatment, universal screening, and accurate determination, is a potent approach for large-scale detection of mycotoxins.

Indexed as

Drug ContaminationFood ContaminationFungiMycotoxinsChromatography, LiquidHigh-Throughput Nucleotide SequencingTandem Mass SpectrometryMycotoxinsEdible and medicinal productFungal contaminationLC-MSMycotoxinSuspect screening

Identifiers

PMID40187728
PMCPMC12766200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.